We provide 1 form of Rolapitant
Rolapitant
552292-08-7
|
500.477
|
4.707
Rolapitant is a neurokinin-1 receptor antagonist. NK1 receptors are located primarily in the gut and central nervous system and are activated by Substance P following chemotherapy administration. Rolapitant is used in combination with other antiemetics for the prevention of delayed nausea and vomiting associated with emetogenic chemotherapy.
Rolapitant
Rolapitant is a neurokinin-1 receptor antagonist. NK1 receptors are located primarily in the gut and central nervous system and are activated by Substance P following chemotherapy administration. Rolapitant is used in combination with other antiemetics for the prevention of delayed nausea and vomiting associated with emetogenic chemotherapy.
Rolapitant
$324/5 mg
(EBC)
1
We provide 0 compound for Rolapitant